Genovate Biotechnology Co Ltd (4130) — Free Cash Flow Generation Index
Genovate Biotechnology Co Ltd (4130) has a Free Cash Flow Generation Index of 0.52x as of December 2025. Free cash flow of NT$8.74 Million represents 1% of operating cash flow (NT$16.93 Million). See Genovate Biotechnology Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genovate Biotechnology Co Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Genovate Biotechnology Co Ltd across 10 annual periods. Explore Genovate Biotechnology Co Ltd (4130) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for Genovate Biotechnology Co Ltd. For the full company profile including market capitalisation, see market value of Genovate Biotechnology Co Ltd.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.40x | NT$-17.63 Million | NT$43.79 Million | NT$61.42 Million | ▼ -193.4% |
| 2024 | 0.43x | NT$23.74 Million | NT$55.11 Million | NT$31.37 Million | ▼ -29.0% |
| 2023 | 0.61x | NT$51.44 Million | NT$84.78 Million | NT$33.34 Million | ▲ +104.1% |
| 2022 | -14.90x | NT$-22.50 Million | NT$1.51 Million | NT$24.01 Million | ▼ -2265.8% |
| 2020 | 0.69x | NT$59.92 Million | NT$87.08 Million | NT$27.01 Million | ▲ +91.5% |
| 2019 | 0.36x | NT$15.96 Million | NT$44.43 Million | NT$25.76 Million | ▼ -13.3% |
| 2018 | 0.41x | NT$26.07 Million | NT$62.88 Million | NT$35.26 Million | ▲ +276.5% |
| 2017 | -0.23x | NT$-7.34 Million | NT$31.27 Million | NT$38.53 Million | ▼ -114.9% |
| 2016 | 1.58x | NT$111.45 Million | NT$70.58 Million | NT$40.87 Million | ▼ -40.5% |
| 2015 | 2.65x | NT$86.28 Million | NT$32.53 Million | NT$53.75 Million | — |